Follow

Submissions from 2004

Knowledge of appropriate treatment for upper respiratory tract infections in community and hospital pharmacists, R. Arthur, D. B. May, R. H. Drew, and E. Dodds Ashley

Anticoagulant prophylaxis in medical patients: An objective assessment, S. Deitelzweig and J. B. Groce

Challenges in variation and responsiveness of unfractionated heparin, J. Francis and J. B. Groce

Cases in hyperlipidemia, S. H. Fuller

New data in the treatment of hyperlipidemia, S. H. Fuller

Update on the treatment of hyperlipidemia, S. H. Fuller

Update on the treatment of hyperlipidemia, S. H. Fuller

Update on the treatment of hyperlipidemia, S. H. Fuller

What does it mean to have a Clinical Coordination Partnership?, S. H. Fuller

Link

A prospective registry of 5,451 patients with ultrasound confirmed deep vein thrombosis, S. Z. Goldhaber, V. Tapson, R. Friedman, J. B. Groce, M. Jaff, G. J. Merli, F. Michota, R. Morrison, J. E. Muntz, C. V. Pollack, and R. Yusen

Thromboembolic disease, J. B. Groce

Pharmacist on quest to prevent blood clots, J. B. Groce and M. Banks

Hematology: Tests of coagulation, J. B. Groce and J. Leumas

Unfractionated heparin and low molecular weight heparin, J. B. Groce and J. Murphy

Keep legs moving during flights, J. B. Groce and T. Reed

Hypertension revisited: JNC-7 and what it means, C. T. Herring

Current topics in antimicrobial therapy, D. B. May

Evaluation of blood pressure control in diabetic participants in a community-based pharmaceutical assistance program for older adults, A. N. McLendon

Review of Alzheimer's disease and memantine literature, A. N. McLendon

Link

Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids, B. L. Meissner, W. M. Moore, J. A. Shinogle, C. E. Reeder, and J. M. Little

Submissions from 2003

Update on the treatment of hyperlipidemia, S. H. Fuller

Link

“Bridging” therapy with low molecular weight heparin in pregnant patients and patients with mechanical prosthetic heart valves, J. B. Groce

Letter to editor, J. B. Groce

ALLHAT trial review -- How will this change practice standards?, C. T. Herring

Updates in treatment of hypertension, C. T. Herring

Updates in treatment of hypertension: Part 2, C. T. Herring

Poisoning, L. C. Larsen and S. H. Fuller

Link

Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels, J. Saw, D. J. Kereiakes, K. W. Mahaffey, R. J. Applegate, G. A. Braden, B. N. Brent, B. R. Brodie, J. B. Groce, G. N. Levine, F. Leya, and D. J. Molinterno

Submissions from 2002

Therapeutic interchange of low molecular heparins, J. Cina, J. B. Groce, J. Fanikos, K. Tsilimingras, and et al.

Getting to the heart of it, Diabetes and CV dz, S. H. Fuller

Getting to the heart of it, Diabetes and CV dz, S. H. Fuller

Getting to the heart of it, Diabetes and CV dz, S. H. Fuller

What's up with blood pressure?, S. H. Fuller

DVT awareness in the institutional setting, J. B. Groce

New program to promote DVT as public health risk, J. B. Groce

Anticoagulation for prevention and treatment of venous thromboembolism (VTE)-Optimizing case management strategies in patients on low molecular weight heparin, J. B. Groce and et al.

Anticoagulant bridging: Prosthetic heart valves, labeling changes, and limiting issues of liability, J. B. Groce, G. J. Vanscoy, and C. Gainor

Asthma guidelines and updates, C. T. Herring

COPERNICUS trial review: How will this change practice standards?, C. T. Herring

Current EPS-2 asthma guideline recommendations, C. T. Herring

Findings of the Copernicus trial: RTC of carvedilol in severe chronic heart failure, C. T. Herring

Findings of the ValHeFT trial: RTC of valsartan in chronic heart failure, C. T. Herring

Methadone dosing guidelines, C. T. Herring

Updates in treatment of hypertension: Part 1, C. T. Herring

ValHEFT trial review: How will this change practice standards?, C. T. Herring

Personal digital assistants as a resource for pharmacy students during experiential learning, M. W. Pound, R. H. Drew, and D. B. May

Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy. Report and Recommendations of the Anticoagulation in Prosthetic Valves and Pregnancy Consensus Report (APPCR) Panel and Scientific Roundtable, E. J. Topol, G. Bosker, H. Cassele, U. Elkayam, S. Z. Goldhaber, R. A. Grimm, J. B. Groce, J. A. Heit, A. James, A. L. Klein, C. Lockwood, G. Merli, C. Pollack, S. A. Spinler, and A. G. Turpie

Submissions from 2001

Evaluation of a computer program for standardizing oral anticoagulation therapy; A new tool for the anticoagulation care provider, K. Baker, J. B. Groce, and D. Patriss

Antithrombotic therapy in the long-term care setting: Reassessing the risk of deep venous thrombosis and pulmonary embolism in the acutely ill medical patient, J. W. Cooper and J. B. Groce

DVT prophylaxis in medically ill patients: A new avenue of clinical management in the long-term care setting, J. W. Cooper and J. B. Groce

Impact of a pharmacy student-based inpatient pneumococcal vaccination program, E. S. Dodds, D. B. May, J. A. Gouveia-Pisano, J. B. Washam, K. B. Fulton, and B. Luna

Ask the pharmacist- Lipids, herbs, weight loss medications, etc., S. H. Fuller

COX-2 inhibitors: Efficacy, safety, CV death?, S. H. Fuller

COX-2 inhibitors: Efficacy, safety, CV death?, S. H. Fuller

Current concepts on Systemic Lupus Erythematosus, S. H. Fuller

A case for the use of low-molecular-weight-heparin: the pharmacoeconomics of LMWHs-making the case, J. B. Groce

Heparin and low molecular weight heparin, J. B. Groce

Low-Molecular-Weight-Heparin differentiation: Issues and evolving evidence, J. B. Groce

Outpatient treatment of deep vein thrombosis with low-molecular-weight-heparins, J. B. Groce

Thromboembolic disease, J. B. Groce

Treatment of deep vein thrombosis using low-molecular-weight heparins, J. B. Groce

Evaluation of a new tool for the anticoagulation care provider: A computer program for standardizing oral anticoagulation therapy, J. B. Groce, K. R. Baker, D. D. Patriss, D. Cender, and et al.

The pharmacoeconomics of LMWHs: Getting the most “bang for the health care buck”, J. B. Groce and J. W. Cooper

Thromboembolic disease: Evolving evidence of clinical consensus and differentiation of low-molecular-weight-heparins, J. B. Groce and S. T. Hains

Treatment of deep vein thrombosis using low-molecular weight heparins, J. B. Groce, B. Perler, V. Tapson, and et al.

Annual credentialing in basic skills / requirements, C. T. Herring

NCEP 3 dyslipidemia guideline review, C. T. Herring

Applying scientific criteria to therapeutic interchange: A balanced analysis of low-molecular-weight heparins, G. J. Merlie, G. J. Vanscoy, T. L. Rihn, and J. B. Groce

Thrombotic complications in the acute medically ill: Update for the medical director, B. Perler, J. B. Groce, and B. L. Hoffman

Submissions from 2000

Pharmacy students initiating Pneumococcal vaccination, E. S. Dodds, R. H. Drew, D. B. May, J. Washam, J. A. Gouveia-Pisano, B. Luna, and K. B. Fulton

Recent changes in vaccination guidelines: an update on vaccines and target population initiatives, E. S. Dodds, D. B. May, and R. H. Drew

Faculty resource guide development, M. A. Fritsch, T. M. Harrison, S. H. Fuller, C. C. DaCamara, and D. B. May

Faculty Resource Guide Development, M. A. Fritsch, T. M. Harrison, S. H. Suller, C. C. da Camara, and D. B. May

Systemic Lupus Erythematosus, S. H. Fuler and C. D. daCamara

Awareness of CAD risk factors, S. H. Fuller

Case studies in hyperlipidemia, S. H. Fuller

The perceived influence of advertising on the selection of OTC medications and herbs, S. H. Fuller

Monitoring of patients on lipid medications in the community, S. H. Fuller, A. Williams, K. Bova, A. Teague-Deaton, S. H. Fuller, and R. W. Chater

Does size* really matter? (*milligram strength of initial dose of oral anticoagulation), J. B. Groce

Pharmacoeconomics of switching LMWHs: process of recent examination by pharmacy and therapeutics committee, Moses Cone Health System, J. B. Groce

Trimethoprim-Sulfamethoxazole, D. B. May

Improvement of transaminase monitoring in patients on troglitazone therapy by clinical pharmacists in a Veterans Affairs primary care clinic, D. Neal, C. T. Herring, and K. Neal

Treating mammalian bite wounds, P. F. Smith, A. M. Meadowcroft, and D. B. May

Submissions from 1999

Conventional and alternative therapies for the treatment of hyperlipidemia, S. H. Fuller

Conventional and alternative therapies for the treatment of hyperlipidemia, S. H. Fuller

Getting to the heart of diabetes, S. H. Fuller

Update of the treatment of hyperlipidemia, S. H. Fuller

Efficacy and safety of low molecular weight heparin determined by heparin level assay for the continued outpatient treatment of pulmonary embolism in a morbidly obese pregnant patient, D. Javino and J. B. Groce

Implementing outpatient treatment of deep vein thrombosis, K. Kitchens, G. Merli, J. B. Groce, and S. Biby

Tetracyclines, D. B. May

Cholesterol management in the diabetes patient, E. P. Mills

Osteoporosis prevention: Are we falling down on the job?, E. P. Mills

Skin disorders of Diabetes mellitus, E. P. Mills

1998 Center for Disease Control treatment guidelines for sexually transmitted diseases (Part II), W. M. Moore

INR elevation associated with diarrhea in a patient receiving warfarin, J. K. Smith, A. Aljazairi, and S. H. Fuller

Submissions from 1998

The treatment of lipid disorders, S. H. Fuller

Anatomy of a narrow therapeutic index drug, J. B. Groce

Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program, J. B. Groce

Drug use in the elderly, E. P. Mills

Troglitazone drug interactions [Letter], S. G. Terra, J. B. Washam, and D. B. May